Clinical Trial Update: A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric Cancer [Phase 3]

View source ↗

Summary

This entry reports the completion of a Phase 3 clinical trial evaluating capecitabine (Xeloda) in patients with advanced or metastatic gastric cancer. The docum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Capecitabine (Xeloda) (Capecitabine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Gastric Cancer | Phase 3 | Status: COMPLETED